MelinJanardanKhandekarMD

Radiation Oncology • Boston, MA

Instructor in Radiation Oncology, Massachusetts General Hospital

Join to view full profile

Dr. Khandekar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khandekar's full profile

Already have an account?

Office
100 Blossom St
Cox 3
Boston, MA 02114
Phone+1 617-726-8650

Fax+1 617-724-2019

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Northwestern University The Feinberg School of MedicineClass of 2006

Certifications & Licensure

ME State Medical License Current
MA State Medical License 2009 - 2026
RI State Medical License 2022 - 2026
NH State Medical License 2021 - 2025
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kina...
Florence K Keane, Beow Y Yeap, Melin J Khandekar, Jessica J Lin, Ibiayi Dagogo-Jack
International Journal of Radiation Oncology, Biology, Physics. 2024-11-20
Noninvasive Quantification of Radiation-Induced Lung Injury Using a Targeted Molecular Imaging Probe.
Eric Abston, Iris Y Zhou, Jonathan A Saenger, Sergey Shuvaev, Eman Akam
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01
1 citations
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer.
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar
Cell Reports. Medicine. 2024-03-19

Press Mentions

$Hypofractionated Image-Guided RT Not the Answer for Chemoradiotherapy-Ineligible NSCLC$
Hypofractionated Image-Guided RT Not the Answer for Chemoradiotherapy-Ineligible NSCLCAugust 20th, 2021
Novel Diabetes Drugs Sensitize Cancer Cells to Chemotherapy AgentsJanuary 2nd, 2018